A PUTATIVE 2ND-CELL-DERIVED ONCOGENE OF THE AVIAN LEUKEMIA RETROVIRUS-E26
A PUTATIVE 2ND-CELL-DERIVED ONCOGENE OF THE AVIAN LEUKEMIA RETROVIRUS-E26
复制标题
DOI:
10.1038/306395a0
复制
发表时间:
1983-01-01
期刊:
影响因子:
64.8
通讯作者:
STEHELIN, D
中科院分区:
文献类型:
--
作者:
LEPRINCE, D;GEGONNE, A;STEHELIN, D
The acute avian leukaemia retroviruses AMV and E26 both induce myeloblastosisin vivoand transform myeloblastsin vitro1–5. Both viruses contain the oncogene v-mybfirst described for AMV6,7. Unlike AMV, E26 has the additional capacity to induce erythroblastosisin vivoand to transform erythroblasts4,5. Previous analyses indicated that the genome of E26 also contained nucleotide sequences distinct from v-myband unrelated to viral replicative genes6,8,9. Using a molecularly cloned E26 provirus, we have now identified a novel nucleotide sequence designated v-ets(forE-twenty-six specific)10of ∼1.5 kilobase pairs (kbp) located next to v-myb. v-etspossesses all the structural characteristics of a putative new oncogene: it has a conserved cellular counterpart c-etswhich is transcribed in some normal chicken cells as a major 7.5-kb polyadenylated RNA. Although our results now await elucidation of their biological significance, we propose that v-etscould be a new oncogene accounting for the additional transforming properties of E26, or potentiating the transforming properties of the v-myboncogene.